Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 14 | 2017 | 100 | 1.330 |
Why?
|
| Thoracoscopy | 2 | 2018 | 9 | 1.230 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 314 | 1.110 |
Why?
|
| Propofol | 2 | 2022 | 19 | 0.980 |
Why?
|
| Methohexital | 1 | 2022 | 4 | 0.890 |
Why?
|
| Vasoconstriction | 1 | 2022 | 40 | 0.880 |
Why?
|
| Intubation, Intratracheal | 3 | 2017 | 70 | 0.770 |
Why?
|
| Humans | 54 | 2022 | 29119 | 0.760 |
Why?
|
| Goals | 1 | 2020 | 36 | 0.740 |
Why?
|
| Catheter Ablation | 1 | 2020 | 62 | 0.710 |
Why?
|
| Hemodynamics | 14 | 2002 | 148 | 0.700 |
Why?
|
| Bronchoscopy | 2 | 2017 | 56 | 0.680 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 72 | 0.680 |
Why?
|
| Cardiology | 1 | 2019 | 72 | 0.670 |
Why?
|
| Bronchi | 1 | 2017 | 41 | 0.590 |
Why?
|
| Stents | 2 | 2008 | 171 | 0.590 |
Why?
|
| Postoperative Complications | 6 | 2017 | 670 | 0.580 |
Why?
|
| Cardiotonic Agents | 9 | 2006 | 39 | 0.540 |
Why?
|
| Collateral Circulation | 1 | 2015 | 8 | 0.530 |
Why?
|
| Heart Failure | 2 | 2020 | 571 | 0.520 |
Why?
|
| Coronary Circulation | 1 | 2015 | 30 | 0.520 |
Why?
|
| Prospective Studies | 11 | 2022 | 2021 | 0.520 |
Why?
|
| Coronary Thrombosis | 3 | 2009 | 15 | 0.520 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2011 | 71 | 0.490 |
Why?
|
| Blood Loss, Surgical | 2 | 2011 | 45 | 0.480 |
Why?
|
| Myocardial Ischemia | 5 | 2002 | 83 | 0.430 |
Why?
|
| Coronary Vessels | 2 | 2015 | 147 | 0.420 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 360 | 0.410 |
Why?
|
| Pulmonary Atelectasis | 1 | 2011 | 2 | 0.410 |
Why?
|
| Epinephrine | 7 | 1998 | 41 | 0.410 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 8 | 0.400 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 16 | 0.400 |
Why?
|
| Mediastinal Neoplasms | 1 | 2011 | 13 | 0.400 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 49 | 0.400 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2007 | 57 | 0.400 |
Why?
|
| Amrinone | 5 | 1998 | 5 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 464 | 0.340 |
Why?
|
| Middle Aged | 27 | 2017 | 10834 | 0.330 |
Why?
|
| Risk Factors | 5 | 2020 | 3537 | 0.330 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 1999 | 59 | 0.330 |
Why?
|
| Anesthesia | 4 | 2011 | 65 | 0.330 |
Why?
|
| Oxygen | 4 | 2020 | 139 | 0.330 |
Why?
|
| Perioperative Care | 1 | 2008 | 58 | 0.320 |
Why?
|
| Heart Rate | 11 | 2007 | 315 | 0.320 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 74 | 0.310 |
Why?
|
| Dobutamine | 5 | 1998 | 43 | 0.310 |
Why?
|
| Male | 33 | 2017 | 17815 | 0.300 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 60 | 0.290 |
Why?
|
| Electric Countershock | 2 | 2022 | 10 | 0.290 |
Why?
|
| Female | 30 | 2017 | 18173 | 0.260 |
Why?
|
| Dopamine | 3 | 2006 | 226 | 0.240 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.240 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.230 |
Why?
|
| Pulmonary Circulation | 1 | 2022 | 4 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.220 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.220 |
Why?
|
| Fentanyl | 5 | 1991 | 33 | 0.210 |
Why?
|
| Postoperative Care | 2 | 2007 | 72 | 0.210 |
Why?
|
| Propanolamines | 2 | 1999 | 11 | 0.200 |
Why?
|
| Postoperative Period | 3 | 2017 | 91 | 0.200 |
Why?
|
| Aged | 16 | 2017 | 9492 | 0.190 |
Why?
|
| Lung | 1 | 2022 | 233 | 0.190 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1997 | 21 | 0.190 |
Why?
|
| Nitroglycerin | 1 | 2000 | 11 | 0.190 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 54 | 0.190 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2007 | 10 | 0.190 |
Why?
|
| Consensus | 1 | 2019 | 68 | 0.180 |
Why?
|
| Hispanic Americans | 1 | 2016 | 904 | 0.180 |
Why?
|
| Anesthetics | 2 | 1989 | 19 | 0.180 |
Why?
|
| Aorta | 1 | 2019 | 103 | 0.170 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 13 | 0.170 |
Why?
|
| Double-Blind Method | 8 | 2000 | 502 | 0.160 |
Why?
|
| Isoproterenol | 2 | 1997 | 18 | 0.160 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 12 | 0.160 |
Why?
|
| Calcium | 4 | 1992 | 297 | 0.160 |
Why?
|
| Ischemia | 1 | 2018 | 92 | 0.160 |
Why?
|
| Cardiac Output, Low | 2 | 1994 | 10 | 0.160 |
Why?
|
| Tachycardia | 1 | 1997 | 3 | 0.160 |
Why?
|
| Premedication | 1 | 1997 | 10 | 0.160 |
Why?
|
| Electroconvulsive Therapy | 1 | 1997 | 25 | 0.150 |
Why?
|
| Heart | 4 | 1995 | 162 | 0.150 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 50 | 0.150 |
Why?
|
| Pharyngitis | 1 | 2017 | 11 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 3719 | 0.150 |
Why?
|
| Cardiac Output | 5 | 1995 | 32 | 0.150 |
Why?
|
| Preanesthetic Medication | 2 | 2002 | 3 | 0.150 |
Why?
|
| Mental Recall | 1 | 1996 | 52 | 0.140 |
Why?
|
| Random Allocation | 1 | 2017 | 213 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2020 | 1688 | 0.140 |
Why?
|
| Adult | 9 | 2017 | 8425 | 0.140 |
Why?
|
| Incidence | 1 | 2019 | 1119 | 0.140 |
Why?
|
| Anesthesiology | 1 | 1996 | 49 | 0.140 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 174 | 0.140 |
Why?
|
| Hemoptysis | 1 | 1995 | 3 | 0.130 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 5 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 169 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 222 | 0.130 |
Why?
|
| Dopamine Agents | 1 | 1994 | 19 | 0.130 |
Why?
|
| Anesthesia, Inhalation | 2 | 2011 | 16 | 0.120 |
Why?
|
| Anesthesia, Intravenous | 3 | 1989 | 6 | 0.120 |
Why?
|
| Myocardial Infarction | 5 | 2000 | 413 | 0.110 |
Why?
|
| Hypertension | 2 | 1997 | 910 | 0.110 |
Why?
|
| Magnesium Sulfate | 2 | 1991 | 6 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3100 | 0.110 |
Why?
|
| Critical Illness | 1 | 1993 | 87 | 0.110 |
Why?
|
| Calcium Chloride | 1 | 1992 | 3 | 0.110 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Coronary Vasospasm | 1 | 1991 | 4 | 0.100 |
Why?
|
| Splanchnic Circulation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 2011 | 8 | 0.100 |
Why?
|
| Bradycardia | 1 | 2011 | 15 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 27 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 96 | 0.100 |
Why?
|
| Kidney | 1 | 1994 | 486 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 21 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 43 | 0.090 |
Why?
|
| Biopsy | 1 | 2011 | 241 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2002 | 81 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 1998 | 641 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Etomidate | 1 | 1989 | 5 | 0.090 |
Why?
|
| Drug Interactions | 4 | 1997 | 80 | 0.090 |
Why?
|
| Pentobarbital | 2 | 1988 | 5 | 0.090 |
Why?
|
| Heart Atria | 1 | 2009 | 62 | 0.080 |
Why?
|
| Echocardiography | 1 | 2009 | 140 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 16 | 0.080 |
Why?
|
| Anesthesia, Conduction | 1 | 2008 | 29 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 39 | 0.080 |
Why?
|
| Aspirin | 1 | 2008 | 62 | 0.080 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1988 | 5 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2016 | 859 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 82 | 0.080 |
Why?
|
| Medical Errors | 1 | 2007 | 36 | 0.080 |
Why?
|
| Cyclic AMP | 2 | 1998 | 40 | 0.070 |
Why?
|
| Intraoperative Care | 1 | 2006 | 48 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 136 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2006 | 190 | 0.070 |
Why?
|
| Blood Pressure | 6 | 2006 | 806 | 0.060 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 55 | 0.060 |
Why?
|
| Young Adult | 1 | 2011 | 2402 | 0.060 |
Why?
|
| Coronary Disease | 2 | 1997 | 200 | 0.050 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2006 | 29 | 0.050 |
Why?
|
| Sex Factors | 2 | 1996 | 631 | 0.050 |
Why?
|
| Age Factors | 3 | 1996 | 1108 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1423 | 0.050 |
Why?
|
| Time Factors | 5 | 2011 | 2001 | 0.050 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 1999 | 3 | 0.050 |
Why?
|
| Sufentanil | 2 | 1989 | 5 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 26 | 0.040 |
Why?
|
| Length of Stay | 2 | 1999 | 292 | 0.040 |
Why?
|
| Antioxidants | 1 | 1999 | 114 | 0.040 |
Why?
|
| Animals | 7 | 1997 | 7299 | 0.040 |
Why?
|
| Heparin | 2 | 1990 | 75 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 1998 | 5 | 0.040 |
Why?
|
| Heart Valves | 1 | 1998 | 15 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1998 | 53 | 0.040 |
Why?
|
| Heart Conduction System | 2 | 1988 | 71 | 0.040 |
Why?
|
| Myocardium | 2 | 1997 | 170 | 0.040 |
Why?
|
| Renal Circulation | 1 | 1997 | 13 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 1997 | 29 | 0.040 |
Why?
|
| Electrocardiography | 3 | 1999 | 568 | 0.040 |
Why?
|
| Chromonar | 1 | 1997 | 1 | 0.040 |
Why?
|
| Coumarins | 1 | 1997 | 2 | 0.040 |
Why?
|
| Nausea | 1 | 1997 | 49 | 0.040 |
Why?
|
| Myocardial Reperfusion | 1 | 1997 | 10 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1997 | 19 | 0.040 |
Why?
|
| Hospital-Patient Relations | 1 | 1996 | 3 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 1999 | 37 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 73 | 0.040 |
Why?
|
| Telephone | 1 | 1996 | 48 | 0.040 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 12 | 0.030 |
Why?
|
| Pyridones | 1 | 1995 | 10 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 122 | 0.030 |
Why?
|
| General Surgery | 1 | 1996 | 81 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 13 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1996 | 148 | 0.030 |
Why?
|
| Natriuresis | 1 | 1994 | 4 | 0.030 |
Why?
|
| Diuresis | 1 | 1994 | 9 | 0.030 |
Why?
|
| Logistic Models | 1 | 1996 | 727 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1994 | 106 | 0.030 |
Why?
|
| Health Status | 1 | 1996 | 368 | 0.030 |
Why?
|
| Dogs | 3 | 1988 | 117 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3112 | 0.030 |
Why?
|
| Ventricular Function, Left | 3 | 2006 | 195 | 0.030 |
Why?
|
| Ephedrine | 1 | 1992 | 3 | 0.030 |
Why?
|
| Shock | 1 | 1993 | 28 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 273 | 0.030 |
Why?
|
| Drug Combinations | 2 | 1989 | 86 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 1992 | 23 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 85 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 1991 | 8 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1991 | 5 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1991 | 16 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 39 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1991 | 30 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 298 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1990 | 1 | 0.020 |
Why?
|
| Protamines | 1 | 1990 | 5 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1991 | 95 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 54 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 150 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 114 | 0.020 |
Why?
|
| Lorazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Scopolamine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Succinylcholine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Equipment Safety | 1 | 1989 | 20 | 0.020 |
Why?
|
| Halothane | 1 | 1988 | 1 | 0.020 |
Why?
|
| Verapamil | 1 | 1988 | 7 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1988 | 5 | 0.020 |
Why?
|
| Propranolol | 1 | 1988 | 16 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1991 | 787 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 239 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 66 | 0.020 |
Why?
|
| Edrophonium | 1 | 1987 | 1 | 0.020 |
Why?
|
| Isoflurane | 1 | 1987 | 1 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 345 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 7 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1987 | 12 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 23 | 0.020 |
Why?
|
| Catheterization | 1 | 1987 | 58 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1987 | 45 | 0.020 |
Why?
|
| Prognosis | 1 | 1991 | 1362 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1987 | 67 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2007 | 24 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1987 | 91 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 41 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 40 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 38 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2006 | 107 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 1998 | 637 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2109 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1992 | 279 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1999 | 110 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 379 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 185 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 799 | 0.010 |
Why?
|
| Milrinone | 1 | 1995 | 1 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1995 | 10 | 0.010 |
Why?
|
| Thyroxine | 1 | 1995 | 16 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1992 | 11 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1992 | 15 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 747 | 0.010 |
Why?
|
| Placebos | 1 | 1992 | 61 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1992 | 28 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1992 | 88 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 21 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1991 | 1 | 0.010 |
Why?
|
| Magnesium | 1 | 1991 | 22 | 0.010 |
Why?
|
| Calcitriol | 1 | 1991 | 23 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 1604 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 39 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1988 | 2 | 0.010 |
Why?
|
| Vecuronium Bromide | 1 | 1987 | 1 | 0.000 |
Why?
|
| Pancuronium | 1 | 1987 | 2 | 0.000 |
Why?
|
| Nitrous Oxide | 1 | 1987 | 4 | 0.000 |
Why?
|
| Atropine | 1 | 1987 | 16 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 21 | 0.000 |
Why?
|
| Probability | 1 | 1987 | 150 | 0.000 |
Why?
|
| Equipment Design | 1 | 1987 | 167 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1987 | 274 | 0.000 |
Why?
|
| Blood Pressure Determination | 1 | 1987 | 94 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1987 | 726 | 0.000 |
Why?
|